Loading...
Loading...
India's linagliptin imports from BRAZIL total $24.5K across 23 shipments from 14 foreign suppliers. DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS leads with $5.3K in import value; the top 5 suppliers together control 82.8% of this origin. Leading Indian buyers include INVENTIA HEALTHCARE LIMITED. This corridor reflects India's pharmaceutical import demand for linagliptin — a diversified sourcing base with multiple active suppliers from BRAZIL.

DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS is the leading Linagliptin supplier from BRAZIL to India, with import value of $5.3K across 1 shipments. The top 5 suppliers — DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS, DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS, DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO), NewLife Medicals (USA). Inc., BILCARE GCS INC — collectively account for 82.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS | $5.3K | 1 | 21.6% |
| 2 | DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS | $5.2K | 2 | 21.3% |
| 3 | DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) | $4.4K | 2 | 17.8% |
| 4 | NewLife Medicals (USA). Inc. | $3.2K | 2 | 13.2% |
| 5 | BILCARE GCS INC | $2.2K | 2 | 8.8% |
| 6 | NEWLIFE MEDICALS (USA). INC. | $1.6K | 2 | 6.4% |
| 7 | NewLife Medicals (USA) Inc. | $581 | 1 | 2.4% |
| 8 | DR. REDDYS FARMACEUTICA DO BRASIL LTDA | $572 | 2 | 2.3% |
| 9 | ZYDUS NIKKHO FARMACEUTICAL LTDA | $572 | 1 | 2.3% |
| 10 | CAMBER FARMACEUTICA LTDA, | $560 | 1 | 2.3% |
| 11 | CAMBER FARMACEUTICAL LTD | $141 | 3 | 0.6% |
| 12 | DR. REDDY'S FARMACEUTICA DO BRASIL LTDA | $140 | 1 | 0.6% |
| 13 | CAMBER FARMACEUTICA LTDA | $63 | 1 | 0.3% |
| 14 | DR REDDYS FARMACEUTICA DO BRASIL LIMITEDA | $10 | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INVENTIA HEALTHCARE LIMITED | $7.4K | 4 | 30.2% |
| 2 | CLIANTHA RESEARCH LIMITED | $5.9K | 2 | 24.0% |
| 3 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $3.9K | 1 | 16.1% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED | $3.2K | 2 | 13.2% |
| 5 | COPMED PHARMACEUTICALS PRIVATE LIMITED | $1.6K | 2 | 6.4% |
| 6 | CLIANS LABS PRIVATE LIMITED | $976 | 2 | 4.0% |
| 7 | DR.REDDY'S LABORATORIES LTD | $712 | 3 | 2.9% |
| 8 | MANKIND PHARMA LIMITED | $581 | 1 | 2.4% |
| 9 | HETERO LABS LIMITED | $204 | 4 | 0.8% |
| 10 | DR REDDYS LABORATORIES LIMITED | $10 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Linagliptin suppliers from BRAZIL to India include DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS, DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS, DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO). The leading supplier is DERMA DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS with import value of $5.3K USD across 1 shipments. India imported Linagliptin worth $24.5K USD from BRAZIL in total across 23 shipments.
India imported Linagliptin worth $24.5K USD from BRAZIL across 23 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Linagliptin sourced from BRAZIL include INVENTIA HEALTHCARE LIMITED, CLIANTHA RESEARCH LIMITED, LAMBDA THERAPEUTIC RESEARCH LIMITED. The largest buyer is INVENTIA HEALTHCARE LIMITED with $7.4K in imports across 4 shipments.
The total value of Linagliptin imports from BRAZIL to India is $24.5K USD, across 23 shipments and 14 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
23 Verified Shipments
14 suppliers, 10 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists